Meningioangiomatosis: What It Is and How It Is Treated

Written by Medicover Team and Medically Reviewed by Dr Hema Swaroop Kurumella , Neurosurgeons

Causes
Find a Doctor
Diagnosis
Treatment
FAQs
Book an Appointment

1. Causes 2. Find a Doctor 3. Diagnosis 4. Treatment 5. FAQs

Meningioangiomatosis is a rare, benign (non-cancerous) lesion of the central nervous system characterized by abnormal proliferation of meningothelial cells and small blood vessels within the cerebral cortex and overlying meninges. It most commonly affects children and young adults and may occur sporadically or in association with neurofibromatosis type 2 (NF2). Although benign, it can cause seizures, headaches, and other neurological symptoms depending on its location.

What Are the Types of Meningioangiomatosis?

Meningioangiomatosis is classified based on its association with inherited disorders.

Sporadic Meningioangiomatosis: The most common form, usually presenting with seizures or headaches.
Neurofibromatosis Type 2 (NF2)-Associated Meningioangiomatosis: Occurs in individuals with NF2 and may be discovered incidentally or during evaluation for other nervous system tumors.

What Are the Symptoms of Meningioangiomatosis?

Symptoms depend on the size and location of the lesion, and some individuals may have no symptoms.

Seizures
Persistent headaches
Cognitive or memory changes
Weakness or sensory changes
Speech difficulties
Visual disturbances
Neurological deficits

What Causes Meningioangiomatosis?

The exact cause of meningioangiomatosis remains unknown. It is believed to result from developmental abnormalities or genetic factors in some individuals.

Association with neurofibromatosis type 2 (NF2)
Developmental abnormalities of the meninges and blood vessels
Rare genetic alterations
Most sporadic cases have no identifiable cause

When Should You See a Doctor for Meningioangiomatosis?

You should consult a neurologist or neurosurgeon if you develop unexplained neurological symptoms or recurrent seizures.

Seek medical evaluation if you experience:

New or recurrent seizures
Persistent or severe headaches
Memory or cognitive difficulties
Weakness, numbness, or coordination problems
Speech or vision changes
Any unexplained neurological symptoms

Early diagnosis allows appropriate treatment, improves seizure control, and helps prevent neurological complications.

Find Neurosurgeons for Meningioangiomatosis Treatment Near You

How Is Meningioangiomatosis Diagnosed?

Diagnosis is based on neurological evaluation, brain imaging, and confirmation by tissue examination when surgery is performed.

Neurological examination
MRI of the brain
CT scan of the brain
Biopsy or histopathological examination following surgical removal
Genetic testing when neurofibromatosis type 2 is suspected

How Is Meningioangiomatosis Treated?

Treatment depends on the severity of symptoms, lesion location, and presence of seizures.

Antiepileptic medications to control seizures
Surgical removal of symptomatic or accessible lesions
Corticosteroids in selected cases to reduce surrounding inflammation
Observation with periodic MRI scans for asymptomatic lesions
Rehabilitation therapies for persistent neurological deficits

Your health is everything - prioritize your well-being today.

Consult Meningioangiomatosis Doctors Today

What Are the Risk Factors for Meningioangiomatosis?

Because meningioangiomatosis is uncommon, only a few risk factors have been identified.

Neurofibromatosis type 2 (NF2)
Young age (children and young adults)
Rare genetic susceptibility
Sporadic developmental abnormalities

What Complications Can Meningioangiomatosis Cause?

Untreated symptomatic lesions may result in persistent neurological problems.

Recurrent seizures
Chronic headaches
Cognitive impairment
Persistent neurological deficits
Reduced quality of life

What Is the Prognosis for Meningioangiomatosis?

The prognosis is generally favorable because meningioangiomatosis is a benign lesion. Many patients experience significant improvement after surgical removal, particularly when seizures are the primary symptom. Long-term outcomes depend on the location of the lesion, the presence of neurological deficits, and seizure control. Regular follow-up with neurological assessment and imaging helps monitor recovery and detect any recurrence or progression.